BNP Paribas Financial Markets’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.92M | Hold |
|
|||||
|
2025
Q2 | $1.62M | Sell |
|
|||||
|
2025
Q1 | $1.81M | Sell |
|
|||||
|
2024
Q4 | $6.14M | Sell |
|
|||||
|
2024
Q3 | $6.63M | Buy |
|
|||||
|
2024
Q2 | $1.93M | Sell |
|
|||||
|
2024
Q1 | $2.47M | Buy |
|
|||||
|
2023
Q4 | $2.36M | Buy |
|
|||||
|
2023
Q3 | $203K | Sell |
|
|||||
|
2023
Q2 | $259K | Buy |
|
|||||
|
2023
Q1 | $222K | Buy |
|
|||||
|
2022
Q4 | $194K | Buy |
|
|||||
|
2022
Q3 | $155K | Buy |
|
|||||
|
2022
Q2 | $147K | Sell |
|
|||||
|
2022
Q1 | $198K | Buy |
|
|||||
|
2021
Q4 | $172K | Sell |
|
|||||
|
2021
Q3 | $4.92M | Buy |
|
|||||
|
2021
Q2 | $5.35M | Buy |
|
|||||
|
2021
Q1 | $151K | Hold |
|
|||||
|
2020
Q4 | $156K | Buy |
|
|||||
|
2020
Q3 | $87K | Hold |
|
|||||
|
2020
Q2 | $86K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $38.8M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $7.62M | Buy |
|
|||||
|
2018
Q3 | $9.71M | Hold |
|
|||||
|
2018
Q2 | $8.6M | Hold |
|
|||||
|
2018
Q1 | $8.37M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $4.25M | Hold |
|
|||||
|
2017
Q2 | $4.3M | Hold |
|
|||||
|
2017
Q1 | $4.18M | Buy |
|